Medicijnen en Levenswetenschappen
Pharmacokinetics
100%
Pharmaceutical Preparations
26%
Pemetrexed
23%
Systematic Reviews
23%
Liquid Chromatography
22%
Cytochrome P-450 CYP3A
22%
Drug Monitoring
21%
Drug Therapy
20%
Aprepitant
20%
Non-Small Cell Lung Carcinoma
18%
olaparib
17%
Ritonavir
17%
Vincristine
15%
Therapeutics
15%
Child
14%
osimertinib
14%
Population
14%
Tandem Mass Spectrometry
14%
Pediatrics
12%
Brain Hypoxia-Ischemia
11%
Xanthine
11%
Hypoxanthine
11%
emicizumab
11%
Allopurinol
11%
7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
11%
Kidney
11%
Confidence Intervals
10%
4-O-deacetyl vinorelbine
10%
Skeletal Muscle
10%
Meta-Analysis
10%
Cisplatin
10%
Pharmacogenetics
10%
Neoplasms
10%
Docetaxel
10%
Paclitaxel
10%
Oxypurinol
9%
Survival
9%
Poverty
9%
Breast Neoplasms
9%
GDC-0973
9%
Uric Acid
9%
Thyroid Neoplasms
9%
Guidelines
8%
Serum
8%
Malnutrition
8%
Dexamethasone
8%
Cytochrome P-450 Enzyme Inhibitors
8%
Mass Spectrometry
8%
Monoclonal Antibodies
8%
Pharmacogenomic Variants
7%
Drug Interactions
7%
dotatate gallium ga-68
7%
Sunitinib
7%
Poly(ADP-ribose) Polymerase Inhibitors
7%
Clofarabine
7%
Busulfan
7%
Randomized Controlled Trials
7%
Ipilimumab
7%
Pharmacology
7%
Peptides
7%
gemcitabine
7%
palbociclib
7%
CD19 Antigens
7%
Phosphotransferases
7%
Paromomycin
6%
Glomerular Filtration Rate
6%
Everolimus
6%
pazopanib
6%
fludarabine
6%
RID
6%
SARS Virus
6%
MDV 3100
6%
Vemurafenib
6%
Biomarkers
6%
pembrolizumab
6%
Long Term Adverse Effects
6%
Body Surface Area
6%
Proof of Concept Study
6%
Deep Learning
6%
Nivolumab
6%
Carvedilol
6%
Chimeric Antigen Receptors
6%
Precision Medicine
6%
Thrombospondin 1
6%
Vinorelbine
6%
Progression-Free Survival
6%
Hepcidins
6%
Creatinine
5%
Ototoxicity
5%
Camptothecin
5%
Immunologic Monitoring
5%
Prospective Studies
5%
Erlotinib Hydrochloride
5%
Adalimumab
5%
Glycopeptides
5%
Capecitabine
5%
Hemangiosarcoma
5%
Renal Cell Carcinoma
5%
Cell Transplantation
5%
Stomatitis
5%
Chemische stoffen
Pharmacokinetics
27%
Phosphotransferase Inhibitor
11%
Cobimetinib
11%
Ritonavir
10%
Gemcitabine
9%
Plasma Concentration
9%
Osimertinib
8%
Peptide
8%
Plasma
8%
Olaparib
8%
Vemurafenib
8%
Pemetrexed
8%
Cytarabine
7%
Sample Preparation Method
7%
Erlotinib
7%
Dose
6%
Vincristine
6%
Drug
6%
2D Liquid Chromatography
6%
Thyroid
5%
Clearance
5%
Paclitaxel
5%
Antineoplastic Agent
5%
Mutation
5%